Pacira Announces FDA Approval of Expanded EXPAREL Label to I

— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies —  — New indications for use as an...

Related Keywords

Pacira Biosciences , Pacira Biosciences Inc , Drug Administration , Nasdaq , Dave Stack , Numerical Rating Scale , Safety Information , Markets ,